Earnings Call · Q3 FY2024·2024-11-06

Q3 24EPS +11.83%·Rev n/aQ2 24EPS -1.03%·Rev n/aQ1 24EPS 0.00%·Rev n/aQ4 23EPS +52.00%·Rev n/a⚠ consensus missing

Royalty Pharma plc RPRX

George Grofik — Senior Vice President, Head of Investor Relations and Communications

Pablo Legorreta — Chief Executive Officer

Marshall Urist — Executive

Chris Hite — Executive

Terry Coyne — Executive

−3.3%1d on move date−5.8% vs SPY3d−4.8%5d−5.6%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RPRX calls or request research access.

More RPRX calls Browse calls Request research access